- Pharmaceutical companies
- Curium
Curium
Phone: +358 14 334 5211
E-mail: orders.finland@curiumpharma.com
Web: https://www.curiumfinland.fi/
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products to customers around the globe. Drawing on years of proven experience, we aim to drive the nuclear medicine industry forward through excellence, reliability and unparalleled service. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. Curium specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.
For detailed contact information visit location pages below.
Curium's locations around the world
Clinical Trials sponsored by Curium
-
Curium US LLCAktiv, inte rekryterandeMetastas från maligna tumör i prostataFörenta staterna, Frankrike, Spanien, Italien
-
Curium US LLCRekryteringProstatacancer | Prostata AdenocarcinomFörenta staterna
-
Curium US LLCAvslutadProstatacancer | Prostata Adenocarcinom | Biokemiskt återfall av malign neoplasm i prostataFörenta staterna
-
Curium US LLCAvslutadMetastas från maligna tumör i prostata (störning)Förenta staterna
-
Curium PET FranceAktiv, inte rekryterandeProstatacancer ÅterkommandeFrankrike
-
Curium US LLCGodkänd för marknadsföringNeuroendokrina tumörer
-
Weill Medical College of Cornell UniversityCurium US LLCRekrytering
-
Veerle RuijtersZonMw: The Netherlands Organisation for Health Research and Development; Curium PET FranceHar inte rekryterat ännuGlioblastom | Radionekros i hjärnanNederländerna